Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord. SE CONNECTER À UN COMPTE LECTEUR CRÉER UN COMPTE LECTEUR
Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results
01 oct. 2018 16h15 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report...
Molecular Diagnostics Market to register 8.5% CAGR to cross $12.5 billion by 2024: Global Market Insights, Inc.
29 août 2018 05h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Global Molecular Diagnostics Market is poised to surpass USD 12.5 billion by 2024; according to a new research report by Global Market...
Fluidigm Announces Second Quarter 2018 Financial Results
02 août 2018 16h05 HE
|
Fluidigm Corporation
Total revenue increases 11 percent to $26.4 million Mass cytometry revenue growth of 32 percent Total consumables revenue growth of 19 percent SOUTH SAN FRANCISCO, Calif., Aug. 02, 2018 (GLOBE...
Polymerase Chain Reaction Market to See 10.6% Annual Growth Through 2022
26 juil. 2018 11h00 HE
|
BCC Research
WELLESLEY, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Growing point of services and the promise of applications for both the food industry and cancer treatment are helping to boost the polymerase...
VITALIBIS, INC. Announces Online Retail Product Launch of Signature 300 Phyto-Cannabinoid Rich (PCR) Hemp Oil and Daily Wellness Capsules
16 juil. 2018 08h00 HE
|
Vitalibis Inc.
LAS VEGAS, July 16, 2018 (GLOBE NEWSWIRE) -- VITALIBIS, INC. (OTCQB:VCBD) a technology based seller of premium, full spectrum phyto-cannabinoid rich (PCR) products, along with personal care and...
Fluidigm to Participate in Upcoming Investor Events
09 mai 2018 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative life science company that develops, manufactures and markets multiparameter mass...
Invivoscribe Announces a Regional “Center of Excellence” Reference Laboratory in Beirut to Offer Specialized Gene Panels
09 mai 2018 06h00 HE
|
Invivoscribe, Inc.
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- Invivoscribe Technologies Inc., a global precision diagnostics company in oncology and personalized molecular medicine, announces a partnership with the...
Molecular Diagnostics Market worth over $12.5 billion by 2024: Global Market Insights, Inc.
11 déc. 2017 07h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Global Molecular Diagnostics Market is poised to surpass USD 12.5 billion by 2024; according to a new research report by Global Market...
Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China
27 juil. 2017 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif. and ZHONGSHAN, China, July 27, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Ascendas Genomics today announced a strategic partnership to develop...
Molecular Diagnostics Market to hit $10bn by 2023: Global Market Insights Inc.
20 mars 2017 06h30 HE
|
Global Market Insights, Inc
Ocean View, Delaware, March 20, 2017 (GLOBE NEWSWIRE) -- The trends outlook report “Molecular Diagnostics Market Size By Infectious Disease (Flu, Tuberculosis, Meningitis, RSV Virus, Hepatitis B,...